水凝胶直肠周围间隔物置入对局限性前列腺癌1.5 T-MRI引导自适应立体定向体部放疗中精囊分次内运动的影响
研究纳入10例接受1.5 T-MRI引导前列腺SBRT(35 Gy/5次)的患者共50次分次,其中5例置入水凝胶间隔物,比较治疗前后MRI上精囊的平移与旋转位移。仅头脚方向平移位移在两组间有统计学显著差异(0.082 mm vs 0.06 mm,p=0.031),作者认为该影响无临床意义,需进一步研究。
要点
- 水凝胶间隔物仅对精囊头脚方向平移位移有统计学显著影响(0.082 mm vs 0.06 mm,p=0.031),作者认为无临床意义。
- 前后、左右方向平移位移及三个方向旋转位移在两组间均无统计学显著差异(p值0.22–0.94)。
- MRI引导每日自适应放疗可更好显示软组织解剖并基于实时状态每日重新计算治疗计划。
核心结论
- 水凝胶间隔物对精囊运动的有益影响仅见于头脚方向平移位移,且无临床意义;需进一步研究以全面探究该装置对精囊运动的潜在贡献。
研究设计与样本
- 研究论文,纳入前10例接受1.5 T-MRI引导前列腺SBRT(35 Gy/5次)的患者共50次分次,其中5例置入水凝胶间隔物,比较治疗前后MRI扫描间精囊的平移与旋转位移,采用Mann-Whitney U检验。
诊断标准与关键数值
- 旋转位移中位数:前后方向置入组0°(范围0.097°/0.112°,SD=0.05°) vs 未置入组0°(范围-0.162°/0.04°,SD=0.07°),p=0.36。
- 旋转位移中位数:左右方向置入组0°(范围-0.1°/0.54°,SD=0.28°) vs 未置入组-0.85°(范围-1.56°/0.124°,SD=0.054°),p=0.22。
- 旋转位移中位数:头脚方向置入组0°(范围-0.121°/0.029°,SD=0.06°) vs 未置入组0°(范围-0.066°/0.087°,SD=0.69°),p=0.53。
- 平移位移中位数:前后方向置入组0.9 mm(范围-0.014 mm/0.031 mm,SD=0.036 mm) vs 未置入组0.030 mm(范围-0.14 mm/0.03 mm,SD=0.032 mm),p=0.8。
- 平移位移中位数:左右方向置入组-0.042 mm(范围-0.047 mm/0.07 mm,SD=0.054 mm) vs 未置入组-0.023 mm(范围-0.027 mm/-0.01 mm,SD=0.023 mm),p=0.94;头脚方向置入组0.082 mm(范围0.06 mm/0.15 mm,SD=0.04 mm) vs 未置入组0.06 mm(范围-0.06/0.08 mm,SD=0.09 mm),p=0.031。
临床应用与阅片要点
- 作者认为,水凝胶间隔物对精囊头脚方向平移位移的统计学显著影响无临床意义。
- 作者指出,MRI引导每日自适应放疗可能成为前列腺SBRT的变革性技术,因其可更好显示软组织解剖并基于实时状态每日重新计算治疗计划。
- 作者提到,直肠球囊或直肠凝胶间隔物等装置因可在前列腺放疗中更好地保护直肠而近年受到关注。
局限性
- 作者指出,目前关于该装置的数据很少(few data are currently available)。
- 作者结论中写明需进一步研究以全面探究该装置对精囊运动的潜在贡献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: MR-guided daily-adaptive radiotherapy is improving the accuracy in the planning and delivery phases of the treatment. Rectal hydrogel-spacer may help in mitigating organ motion, but few data are currently available.
METHODS: We aimed to assess any potential impact of the device on seminal vesicles motion by measuring translational and rotational shifts between the pre- and post-treatment MRI scans of a total of 50 fractions in the first 10 patients who underwent MR-guided prostate SBRT (35 Gy/5 fx). Of them, five patients received the hydrogel-spacer. The comparative analysis was performed using the Mann-Whitney U-test.
RESULTS: Median rotational shifts were: in anteroposterior 0° (range, 0.097°/0.112°; SD = 0.05°) vs 0° (-0.162/0.04°; SD = 0.07°) in the no-spacer subgroup (p = 0.36); lateral shifts were 0° (-0.1°/0.54°; SD = 0.28°) vs -0.85° in the no-spacer cohort (-1.56°/0.124°; SD = 0.054°; p = 0.22). Cranio-caudal shifts were 0° (-0.121°/0.029°; SD = 0.06°) in the spacer-cohort vs 0° (-0.066°/0.087°; SD = 0.69°; p = 0.53). Median translational shifts were: in anteroposterior 0.9 mm (-0.014 mm/0.031 mm; SD = 0.036 mm) in the spacer-group vs 0.030 mm (-0.14 mm/0.03 mm; SD = 0.032 mm; p = 0.8); latero-lateral shifts were -0.042 mm (-0.047 mm/0.07 mm; SD = 0.054 mm), vs -0.023 mm (-0.027 mm/-0.01 mm; SD = 0.023 mm) in the no-spacer group (p = 0.94). In cranio-caudal, statistically significant shifts were reported: 0.082 mm (0.06 mm/0.15 mm; SD = 0.04 mm) vs 0.06 mm (-0.06/0.08 mm; SD = 0.09 mm) in the no-spacer cohort (p = 0.031).
CONCLUSIONS: A favorable impact of the hydrogel-spacer on seminal vesicles motion was observed only in cranio-caudal translational shifts, although being not clinically significant. Further studies are required to fully investigate the potential contribution of this device on vesicles motion.
ADVANCES IN KNOWLEDGE: MR-guided daily adaptive radiotherapy may represent a game changer for prostate stereotactic body radiotherapy, given the possibility to better visualize soft-tissues anatomy and to daily recalculate the treatment plan based on real-time conditions. The use of devices like rectal ballon or rectal gel spacers has gained interest in the last years for the possibility to better spare the rectum during prostate radiotherapy. This is one of the first experiences exploring the role of rectal spacer on seminal vesicles intrafraction motion during MR-guided SBRT for prostate cancer.
引用
- Mazzola R, Sicignano G, Cuccia F, et al. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer. Br J Radiol. 2021. PMID: 34283646. doi:10.1259/bjr.20210521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。